SAN DIEGO, April 25, 2018 -- The Shareholders Foundation, Inc. announces that a deadline is comping up on May 1, 2018 in the lawsuit that was filed for certain investors in shares of Ulta Beauty Inc (NASDAQ:ULTA).
Investors, who purchased shares of Ulta Beauty Inc (NASDAQ:ULTA), have certain options and for certain investors are short and strict deadlines running. Deadline: May 1, 2018. NASDAQ: ULTA investors contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On March 2, 2018, a lawsuit was filed against Ulta Beauty Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that the Company was engaged in the widespread practice of repackaging returned cosmetics and re-shelving them alongside unblemished products to sell at full retail price, and that as a result of the foregoing, Ulta’s public statements were materially false and misleading at all relevant times.
Those who purchased Ulta Beauty Inc (NASDAQ:ULTA) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108


Bathla Group Hires Administrators as Australia Housing Slump Deepens
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Tesla Raises Cybertruck Prices by $5,000 in US
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Trump Buys SpaceX Shares After Record IPO
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Google Expands Gemini Enterprise With AI Tools for Legal Sector
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 



